Systemic infection and limited replication of SHIV vaccine virus in brains of macaques inoculated intracerebrally with infectious viral DNA

Virology

Volumn 301, Issue 1, 2002, Pages 130-135

  Smith, Marilyn S ^a,b   Niu, Yafen ^a,b   Li, Zhuang ^a,b   Adany, Istvan ^a,b   Pinson, David M ^b   Liu, Zhen Qian ^a,b   Berry, Tanesha ^a   Sheffer, Darlene ^a,b   Jia, Fenglan ^a,b   Narayan, Opendra ^a,b  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SIMIAN IMMUNODEFICIENCY VIRUS VACCINE; VIRUS DNA; VIRUS MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFECTION; BRAIN REGION; CONTROLLED STUDY; EXPERIMENTAL INFECTION; GENE EXPRESSION; GENE IDENTIFICATION; HISTOPATHOLOGY; INOCULATION; LYMPHOID TISSUE; MACACA; MOLECULAR CLONING; NONHUMAN; PARIETAL LOBE; PLASMID; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; SPINAL CORD; VIRUS DETECTION; VIRUS GENOME; VIRUS INFECTION; VIRUS REPLICATION;

MACACA; SIMIAN-HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0036394888     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2002.1548     Document Type: Article

References (15)

1. Boche, D., Gray, F., Chakrabarti, L., Hurtrel, M., Montagnier, L., and Hurtrel, B. (1995). Low susceptibility of resident microglia to simian immunodeficiency virus replication during the early stages of infection. Neuropathol. Appl. Neurobiol. 21, 535-539.
2. Genetics Computer Group (GCG). (1999). Madison Wisc. Wisconsin Package Version 10.2.
3. Hofmann-Lehmann, R., Swenerton, R. K., Liska, V., Leutenegger, C. M., Lutz, H., McClure, H. M., and Ruprecht, R. M. (2000). Sensitive and robust one-tube real-time reverse transcriptase-polymerase chain reaction to quantify SIV RNA load: Comparison of one- versus two-enzyme systems. AIDS Res. Hum. Retroviruses 16, 1247-1257.
4. Joag, S. V., Adany, I., Li, Z., Foresman, L., Pinson, D. M., Wang, C., Stephens, E. B., Raghavan, R., and Narayan, O. (1997). Animal model of mucosally transmitted human immunodeficiency virus type 1 disease: Intravaginal and oral deposition of simian/human immunodeficiency virus in macaques results in systemic infection, elimination of CD4+ T cells, and AIDS. J. Virol. 71, 4016-4023.
5. Joag, S. V., Li, Z., Foresman, L., Stephens, E. B., Zhao, L. J., Adany, I., Pinson, D. M., McClure, H. M., and Narayan, O. (1996). Chimeric simian/human immunodeficiency virus that causes progressive loss of CD4+ T cells and AIDS in pig-tailed macaques. J. Virol. 70, 3189-3197.
6. Joag, S. V., Liu, Z. Q., Stephens, E. B., Smith, M. S., Kumar, A., Li, Z., Wang, C., Sheffer, D., Jia, F., Foresman, L., Adany, I., Lifson, J. D., McClure, H. M., and Narayan, O. (1998). Oral immunization of macaques with attenuated vaccine virus induces protection against vaginally transmitted AIDS. J. Virol. 72, 9069-9078.
7. Kumar, A., Lifson, J. D., Li, Z., Jia, F., Mukherjee, S., Adany, I., Liu, Z., Piatek, M., Sheffer, D., McClure, H. M., and Narayan, O. (2001). Sequential immunization of macaques with two differentially attenuated vaccines induced long-term virus-specific immune responses and conferred protection against AIDS caused by heterologous simian human immunodeficiency virus (SHIV89.6P). Virology 279, 241-256.
8. Lamb-Wharton, R., Joag, S. V., Stephens, E. B., and Narayan, O. (1997). Primate models of AIDS vaccine development. AIDS 11, S121-S126.
9. Li, J., Lord, C. I., Haseltine, W., Letvin, N. L., and Sodroski, J. (1992). Infection of monkeys with a chimeric HIV-1/SIVmac virus that expresses the HIV-1 envelope glycoproteins. J. Acquir. Immune Defic. Syndr. 5, 639-646.
10. Liu, Z. Q., Muhkerjee, S., Sahni, M., McCormick, D. C., Leung, K., Li, Z., Gattone, V. H., Tian, C., Doms, R. W., Hoffman, T. L., Raghavan, R., Narayan, O., and Stephens, E. B. (1999). Derivation and biological characterization of a molecular clone of SHIV(KU-2) that causes AIDS, neurological disease, and renal disease in rhesus macaques. Virology 260, 295-307.
11. Mackay, G. A., Niu, Y., Liu, Z. Q., Mukherjee, S., Li, Z., Adany, I., Buch, S., Zhuge, W., McClure, H. M., Narayan, O., and Smith, M. S. (2002). Presence of intact vpu and nef genes in non-pathogenic SHIV is essential for acquisition of pathogenicity of this virus by serial passage in macaques. Virology 295, 133-146.
12. Sharkey, M. E., Teo, I., Greenough, T., Sharova, N., Luzuriaga, K., Sullivan, J. L., Bucy, R. P., Kostrikis, L. G., Stevenson, M., Veryard, C., Davaro, R. E., Cheeseman, S. H., Daly, J. S., Bova, C., Ellison, R. T. I., Mady, B., Lai, K. K., Moyle, G., Nelson, M., Gazzard, B., and Shaunak, S. (2000). Persistence of episomal HIV-1 infection intermediates in patients on highly active anti-retroviral therapy. Nat. Med. 6, 76-81.
13. KU inoculated into immunized macaques caused infection, but virus burdens progressively declined with time. J. Virol. 74, 10489-10497.
14. Stephens, E. B., Mukherjee, S., Liu, Z. Q., Sheffer, D., Lamb, W. R., Leung, K., Zhuge, W., Joag, S. V., Li, Z., Foresman, L., Adany, I., and Narayan, O. (1998). Simian-human immunodeficiency virus (SHIV) containing the nef/long terminal repeat region of the highly virulent SIVsmmPBj14 causes PBj-like activation of cultured resting peripheral blood mononuclear cells, but the chimera showed no increase in virulence. J. Virol. 72, 5207-5214.
15. Wyand, M. S., Manson, K., Montefiori, D. C., Lifson, J. D., Johnson, R. P., and Desrosiers, R. C. (1999). Protection by live, attenuated simian immunodeficiency virus against heterologous challenge. J. Virol. 73, 8356-8363.